Broadsheet: Your source for breaking news & in-depth analysis on Politics, Business, Tech, World events, Culture, Sports, Health & more. Stay informed.
health

Jesy Nelson Expresses Outrage Over Staggered SMA Screening Rollout in UK

Jesy Nelson Expresses Outrage Over Staggered SMA Screening Rollout in UK

Singer Criticizes Inconsistent Health Policy

Jesy Nelson, formerly of the group Little Mix, has publicly expressed her profound disappointment and anger regarding a recent parliamentary discussion concerning spinal muscular atrophy (SMA) testing. Nelson, whose twin children, Ocean Jade and Story Monroe, have been diagnosed with the muscle-wasting condition, has been a vocal advocate for universal newborn screening for SMA.

Early detection of SMA is crucial, as timely treatment can significantly alter the disease's progression, potentially preventing severe outcomes, including death within two years if left undiagnosed. While Scotland implemented screening in March, a UK-wide program is slated for a partial introduction, a decision Nelson finds unacceptable.

"You are basically telling me that if you live in a certain postcode, you're not as important," Nelson stated on Instagram, deeming the situation "outrageous." She questioned the ethics of a system that offers life-changing screening to some while denying it to others based on geographical location.

Parliamentary Debate and Limited Rollout

The parliamentary debate on Monday was spurred by a petition initiated by Nelson, which garnered over 150,000 signatures. Although it was announced that SMA screening would begin in October 2026, three months earlier than initially planned, it will only be accessible to 72% of newborns across the UK. Major cities such as Bristol, Cambridge, Leeds, Liverpool, Oxford, and Portsmouth are among the areas that will not be included in this initial phase. Wales and Northern Ireland, which manage their own health policies, have not yet declared their screening plans.

Public health minister Sharon Hodgson defended the phased implementation, citing limitations in testing facilities. She explained that the staggered approach aligns with the advice of the UK National Screening Committee, which aims to assess the efficacy of screening and the associated costs to the NHS. The trial will involve seven of the 13 NHS testing laboratories in the UK, with Hodgson noting that the remaining six currently lack the necessary equipment for testing.

Calls for Universal Access

MPs from affected constituencies voiced strong objections during the debate. Amanda Martin, MP for Portsmouth North, expressed alarm that parents in her area would be denied access to the tests, questioning why babies in Portsmouth should be considered less important. Ruth Jones, MP for Newport West and Islwy, highlighted that even Ukraine had managed to initiate newborn SMA screening amidst conflict, underscoring concerns about the UK's slower progress.

Nelson, who attended the debate, conveyed her devastation over the lack of urgency. She tearfully recounted how early diagnosis and treatment could have drastically improved her children's lives, potentially allowing them to walk and avoiding the need for breathing machines and constant care. She also shared an anecdote about showing Minister Hodgson a video illustrating the stark difference in outcomes between two sisters with SMA, one treated early and one not, suggesting a potential lack of full awareness regarding the treatment's impact.

Muscular Dystrophy UK welcomed the debate but reiterated its commitment to advocating for a comprehensive, UK-wide screening program, emphasizing an end to the "postcode lottery."

SMA Treatment and Screening

In 2021, the NHS approved Zolgensma, a gene therapy drug that can significantly benefit babies with SMA by delivering a healthy copy of the affected gene. However, the timing of administration is critical to prevent irreversible damage to the nervous system. Currently, SMA screening is only performed on newborns with a sibling already diagnosed with the condition. SMA UK advocates for the inclusion of SMA in the existing newborn blood spot test, which screens for ten other rare but serious conditions. The charity estimates that approximately 47 babies were born with SMA in the UK in 2024, with about one in 40 people carrying the gene that can cause the disease.

Source: Jesy Nelson 'outraged' after MPs debate muscle condition that affects her twins